eosine yellowish-(ys) has been researched along with methylprednisolone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Tan, YJ; Teng, E; Ting, AE | 1 |
Faivre, JC; Granel-Brocard, F; Modesto, A; Pointreau, Y; Tao, YG | 1 |
Kang, PD; Li, QH; Wang, QR; Yang, ZY; Zhang, WL | 1 |
3 other study(ies) available for eosine yellowish-(ys) and methylprednisolone
Article | Year |
---|---|
A small inhibitor of the interaction between Bax and Bcl-X(L) can synergize with methylprednisolone to induce apoptosis in Bcl-X(L)-overexpressing breast-cancer cells.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Blotting, Western; Breast Neoplasms; Drug Synergism; Eosine Yellowish-(YS); Female; Gene Expression Regulation, Neoplastic; Humans; Methylprednisolone; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Transfection; Tumor Cells, Cultured; Up-Regulation | 2003 |
[Evaluation and management of acute radiation dermatitis].
Topics: Adjuvants, Immunologic; Analgesics; Anti-Infective Agents, Local; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bandages, Hydrocolloid; Calendula; Cetuximab; Dermatologic Agents; Eosine Yellowish-(YS); Ethanolamines; Glucocorticoids; Humans; Hyaluronic Acid; Methylprednisolone; Phytotherapy; Radiodermatitis; Radiotherapy; Radiotherapy Dosage; Severity of Illness Index; Skin Care | 2012 |
Abnormal hyperplasia of chondrocytes in a rat model of glucocorticoid-induced osteonecrosis of the femoral head.
Topics: Animals; Chondrocytes; Eosine Yellowish-(YS); Femur Head; Femur Head Necrosis; Glucocorticoids; Hematoxylin; Hyperplasia; Lipopolysaccharides; Methylprednisolone; Rats; Tolonium Chloride; X-Ray Microtomography | 2022 |